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OVERVIEW
Control of animal infectious diseases at the within-host scale
Viral dynamics
Immune dynamics
Exposure
- Strain virulence 
- Host susceptibility
Variability factors
Infectiousness
Within-host dynamics
Infection spread
Between-host dynamics
Application: Porcine Respiratory and Reproductive Syndrome virus (PRRSv)
Method: mathematical model of the within-host dynamics
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APPLICATION
Porcine Respiratory and Reproductive Syndrome virus
– Major concern for swine industry
– Transmission by close contacts
– Vaccines not efficient enough to eradicate the infection
Need to better understand the within-host dynamics
Viral dynamics
Immune dynamics
Exposure
- Strain virulence 
- Host susceptibility
Variability factors
Infectiousness
Within-host dynamics
Infection spread
Between-host dynamics
?
?
?
→What drive the infection duration and severity?
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MODEL OVERVIEW
– Target cells of PRRSv: Pulmonary macrophages
– Innate immune functions of macrophages:
∗ Phagocytosis
∗ Cytokine synthesis
∗ Adaptive response activation & orientation
⇒ virus triggers & hampers the immune response
MODEL: ODE system with 14 state variables: virus, 4 innate and 3 adaptive
cells, 6 cytokines; and 30 parameters
– Detailed innate immune response
– Orientation of the adaptive response (cellular, humoral, regulatory)
– Cytokine syntheses & regulations (pro-inflammatory, antiviral,
immuno-modulatory)
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BASIS: MACROPHAGE-VIRUS INTERACTIONS
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REGULATIONS BY CYTOKINES AND ADAPTIVE RESPONSE
Susceptible macrophage (MS) point of view:
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Positive regulations:
  - Ampliﬁcation: [1+K+(Ci)]
  - Activation: K+(Ci)
Negative regulations: K -(Ci)
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REGULATIONS BY CYTOKINES AND ADAPTIVE RESPONSE
Virus (V ) point of view:
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→What is missing?
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ADAPTIVE RESPONSE ORIENTATION
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CYTOKINE SYNTHESIS
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PRRSV INFECTION & CALIBRATION
Infection
- Phagocytosis (Mp)
- Cytolysis (NK, Rc)
- Infection, replication (Mi)
- Viral neutralisation (Rh)
ExposureInfectiousness
Ai cytokines 
Imcytokines
Within-host dynamics Characteristics:
- High levels of Im- Low levels of Ai
- High but ineﬃcient Rh- Low but eﬃcient Rc
- Low phagocytosis rate
- High infection rate
- High replication rate
LONG INFECTION
MODEL CALIBRATION
Few & highly heterogeneous 
data -> ad hoc method:
  - Exploration
  - Selection
  - Sensitivity analysis
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DEFINITION OF SCENARIOS
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Exposure scenarios:
Design: 3 Svir x 6 DE x 6 NE = 108 scenarios
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RESULTS: VIRAL DYNAMICS
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Viral titer among all scenarios
Which scenario characteristics determine the viral dynamics?
  -> Quantiﬁed thanks to sensitivity analysis (indices in %):
Dynamics
Viral peak (Vmax)
Infection duration (DI)
Infection severity (      ) 
Inﬂuence of scenario characteristics
ΣV
NE (40%), DE (30%), Svir (25%)
NE(80%), DE (4%), NE x DE (16%)
Svir(89%), NE(9%), DE (2%)
NE(100%) 
Viral characteristics
NE levels:
L1 -> L6
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RESULTS: VIRAL DYNAMICS
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Which scenario characteristics determine the viral dynamics?
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FOCUS: 2 SCENARIOS OF PARTICULAR INTEREST
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Exposure Exposure
DI = 120 d DI = 120 d
x S3 x S1 - Opposed exposure characteristics:   *      long vs      short duration
   *       low vs      high intensity
- Opposed virulence levels: 
 S3 promoting infection, replication  
       & immuno-modulatory cytokines 
 S1 promoting phagocytosis & anti-
       viral cytokines
1 2
1 2 Viral titer Viral titer
Within-host dynamics:
– Same infection duration, but contrasted infection severities
– Opposed immune responses:
∗ ¬ low vs ­ high immune response activation
∗ ¬ low vs ­ high % of antiviral cytokines
∗ ¬ high vs ­ low % of cellular response
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CONCLUSION
– Within-host↔ Between-host
∗ To understand/control/predict the within-host dynamics, we need:
(1) Exposure characteristics, depending on the contact structure
(2) Virulence/susceptibility levels, heterogeneous at the population scale
∗ To understand/control/predict the between-host dynamics, we need:
(1) Infection duration, which determines the infectiousness duration
(2) Infection severity, which determines the infectiousness level
(3) Type of immune response, which determines the host protection level and the
vaccine efficiency
– Forthcoming: Exploration of vaccine efficiency at the within-host level
– Extension to other pathogens
Thank you for your attention!
